TYLER LAUFFER: Open Payments
NPI 1639883325 · SUSQUEHANNA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$893 in 51 payments from 16 companies in 2025. Trend: 2023 $48 · 2024 $563 · 2025 $893
Food & beverage: $893
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $178 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $167 |
| Merck Sharp & Dohme LLC | 7 | $156 |
| Becton, Dickinson and Company | 1 | $49 |
| Novo Nordisk Inc | 2 | $43 |
| BridgeBio Pharma, Inc. | 2 | $40 |
| Amgen Inc. | 2 | $40 |
| HEARTFLOW, INC. | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
Products named: LEQVIO, JARDIANCE, VERQUVO, Attruby, REPATHA, FFRct, Kerendia, EVKEEZA.
Industry payments across PA — which companies pay providers there.
